ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 676353 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 676353; 2) Community: the network communities that were significantly associated with the response to NSC 676353; 3) Molecule: the relationships between components within communities and NSC 676353; 4) MDR: the compounds that were significantly associated with the NSC 676353.

NSC Compound Enrichment Correlation
NSC 697535 Null 0.011265111688021 0.11912571
NSC 715407 Null 0.011265111688021 0.40848603
NSC 718781 Erlotinib hydrochloride 0.011265111688021 0.095611725
NSC 726217 Combretastatin A4-analogue 0.011265111688021 -0.049889385
NSC 741425 3,7-di(trifluoromethyl)-2-naftoylquioxaline 1,4-dioxide 0.011265111688021 -0.020568648
NSC 743695 Null 0.011265111688021 -0.04018591
NSC 748147 5-methyl-2-{[(2)-3-phenylprop-2-enoyl]amino}benzamide 0.011265111688021 0.0013140638
NSC 752346 Null 0.011265111688021 -0.090975554
NSC 756483 SB-742864 0.011265111688021 0.11421677
NSC 762346 Null 0.011265111688021 -0.11142304
Total:93  Current:28    [First] [Prev] [Next] [Last]